NL-OMON39800
Completed
Phase 4
Prospective, randomized, open label trial of six vs. twelve months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction. - DAPT-STEMI
Maasstadziekenhuis0 sites580 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- DAPT treatment after PCI
- Sponsor
- Maasstadziekenhuis
- Enrollment
- 580
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Trial is onging in other countries
Investigators
Eligibility Criteria
Inclusion Criteria
- •STEMI patients between 18\-85 years, who underwent PCI with second generation DES implantation
Exclusion Criteria
- •Key Exclusion Criteria Enrollment: Intolerance to Aspirin, Plasugrel, Ticagrelor, Heparin, Bivaluridin, Everoliumus or Zotarolimus.
- •Known bleeding diathesis or known coagulopathy.
- •Planned elective surgical procedure necessitating interruption of dual antiplatelet therapy during the first 6 months after randomization.;Key Exclusion Criteria Randomization:
- •Occurrence of death, myocardial infarction, stent thrombosis and target vessel or lesion revascularization during the first 6 months after inclusion.
- •Stroke or bleeding requiring discontinuation of DAPT during the first 6 months after inclusion.
- •Oral anticoagulant therapy with coumarin derivates.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
A randomized, open-label, parallel-group, multi-center study of adding edoxaban or clopidogrel to aspirin to maintain patency in subjects with peripheral arterial disease following femoropopliteal endovascular intervention-edoxaban in peripheral arterial disease (ePAD)narrowing of the peripheral arteries (mostly in the legs)periferal arterial disease10003216NL-OMON40071Daiichi Sankyo Development Ltd14
Completed
Phase 4
A randomised, open-label clinical trial assessing the efficacy and safety of mycophenolate mofetil versus azathioprine for induction of remission in treatment naive autoimmune hepatitisAutoimmune hepatitis1001965410003816NL-OMON52983eids Universitair Medisch Centrum66
Completed
Phase 3
A randomised, open-label clinical trial assessing the efficacy of octreotide to decrease iron infusion and blood transfusion requirements in patients with refractory anaemia due to gastrointestinal bleeding from angiodysplasias.angiodysplasiavascular malformation10017959NL-OMON44271Maag-, darm- en leverziekten62
Completed
Not Applicable
An open-label, adaptive multiple-dose study to investigate the pharmacokinetics and pharmacodynamics of RO7234292 in csf and plasma, and safety and tolerability following intrathecal administration in patients with Huntington's disease.Chronic Progressive Choreadegenerative chorea1002929910029317NL-OMON49037Hoffmann-La Roche4
Completed
Phase 2
A randomised, controlled, double-blind trial to investigate the effects of a new infant formula on growth, tolerance and safety in healthy term infants.effect op de groei van zuigelingeneffects on growthNL-OMON39783utricia Research - Centre for Specialised Nutrition121